New Therapy Strategy for Prostate Cancer: Amanita phalloides Treatment Stabilizes Best Without Pre-treatments (Observational Study Pre-protocol)
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2017, Vol 21, Issue 3
Abstract
Background: Amanita phalloides (Amanita) contains amanitin, inhibiting RNA polymerase II. Partial inhibition with amanitin influences tumor cell - but not normal cell - activity. Patients treated with Amanita often gain a stable disease state without further tumor growth. Aim: Several therapies for prostate cancer are in use so far. This study evaluates the implementation of the Amanita therapy into the therapeutic regimen of today. Methods: 38 Patients with diagnosed prostate cancer were treated with Amanita alone. Prostate specific antigen (PSA) was used as a parameter for tumor cell growth. Data about previous therapies like anti androgen treatment, prostatectomy, chemotherapy or radiation and progression state of the disease were collected, and relationships analyzed. Results: Some patients could be stabilized with Amanita, evidenced by previously increasing PSA that did not increase for at least six months during Amanita therapy. In some patients PSA levels further increased despite Amanita therapy indicating immediate therapy resistance. Analyses revealed that successful Amanita therapy is strongly associated with beginning therapy early, while progressive disease states are often resistant to Amanita (p-value 0,005). Correlation between tumor specific pre-treatments and Amanita therapy resistance is significant: all patients without pre-treatment could be stabilized with Amanita (p-value 0,007). Conclusions: Amanita therapy can reduce tumor growth best in patients without previous treatments, and was most effective in patients without tumor progression. Therefore Amanita should be used first as a tumor specific therapy. Anti androgen treatment, chemotherapy, radiation or prostatectomy can be applied at later stages.
Authors and Affiliations
Isolde Riede
Keywords
Related Articles
- EP ID EP311867
- DOI 10.9734/BJMMR/2017/32673
- Views 85
- Downloads 0
OCT- An Emerging Diagnostic Tool in Sensing Marginal Integrity of Nano Composites
Objectives: The purpose of the present research was to demonstrate images of failure into the structure of nano composites using optical coherence tomography. Methods: Ten human third mandibular molars were taken in the...
Levofloxacin Reverses Hydroxyzine Induced Psychomotor Performance Deterioration: A Randomized Crossover Study
Background: Levofloxacin is a third generation fluoroquinolone chemotherapeutic agent used in the treatment of severe and resistant bacterial infections; it exerts antibacterial effects in both blood and inflamed tissues...
Reproductive Hormonal Profile of Post-menopausal Women in Ebonyi State, Nigeria
Background: Assessment of the concentrations of reproductive hormones during post-menopause has been suggested as a confirmatory test for menopause due to irregularities in rise and fall of sex hormones in menopausal tra...
Patient Factors that Predict Complicated Hernia Presentation Using the National Hospital Ambulatory Medical Care Survey (NHAMCS)
Aims: Patient age and insurance status can lead to presentation with complicated hernias. Surgery for complicated hernias results in greater morbidity, mortality, and healthcare costs compared to elective repair of uncom...
Interventional Management of High-risk Patients with Takayasu’s Arteritis
Takayasu’s arteritis is a chronic vasculitis affecting aorta and its branches. We report a case series of Takayasu’s disease. Percutaneous intervention with stent implantation is better choice for stenosis and occlusion...